Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 2
1980 1
1983 3
1984 3
1985 5
1986 5
1987 11
1988 2
1989 2
1990 6
1991 4
1992 5
1993 3
1994 3
1995 2
1996 3
1997 1
1999 1
2002 4
2003 2
2004 2
2005 1
2006 2
2007 6
2008 2
2009 1
2011 2
2012 6
2013 4
2014 3
2015 7
2016 6
2017 9
2018 13
2019 11
2020 18
2021 14
2022 17
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Relative Efficacy of Minoxidil and the 5-alpha Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Gupta AK, et al. JAMA Dermatol. 2022 Mar 1;158(3):266-274. doi: 10.1001/jamadermatol.2021.5743. JAMA Dermatol. 2022. PMID: 35107565 Free PMC article.
IMPORTANCE: There are knowledge gaps regarding the relative efficacy of 3 commonly used drugs for androgenetic alopecia (AGA), namely, minoxidil and the two 5-alpha reductase inhibitors dutasteride and finasteride. OBJECTIVE: To examine the relative efficacy of any dose an …
IMPORTANCE: There are knowledge gaps regarding the relative efficacy of 3 commonly used drugs for androgenetic alopecia (AGA), namely, mi
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P, Srisuwanwattana P, Chalermroj N, Khunkhet S. Suchonwanit P, et al. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2257-2263. doi: 10.1111/jdv.15171. Epub 2018 Jul 20. J Eur Acad Dermatol Venereol. 2018. PMID: 29972712 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in men with androgenetic alopecia. ...RESULTS: At week 24, the combined solution of finasteride and minoxidil was signif …
OBJECTIVE: To compare the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil
Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
Ghonemy S, Alarawi A, Bessar H. Ghonemy S, et al. J Dermatolog Treat. 2021 Mar;32(2):236-241. doi: 10.1080/09546634.2019.1654070. Epub 2019 Oct 21. J Dermatolog Treat. 2021. PMID: 31403367 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety of 5% topical minoxidil with 10% topical minoxidil and placebo in AGA treatment. ...No reported sexual dysfunction in all three groups. CONCLUSION: Five percent of topical minoxidil was moderately superior to 10% …
OBJECTIVE: To compare the efficacy and safety of 5% topical minoxidil with 10% topical minoxidil and placebo in AGA treatment. …
Pumpkin seed oil vs. minoxidil 5% topical foam for the treatment of female pattern hair loss: A randomized comparative trial.
Ibrahim IM, Hasan MS, Elsabaa KI, Elsaie ML. Ibrahim IM, et al. J Cosmet Dermatol. 2021 Sep;20(9):2867-2873. doi: 10.1111/jocd.13976. Epub 2021 Feb 12. J Cosmet Dermatol. 2021. PMID: 33544448 Clinical Trial.
AIM: The present study aimed to investigate the clinical efficacy of pumpkin seed oil (PSO) in the treatment of female pattern hair loss (FPHL) and compare its effects with minoxidil 5% foam. METHODS: Patients with FPHL were randomly assigned to pumpkin seed oil (n = 30; g …
AIM: The present study aimed to investigate the clinical efficacy of pumpkin seed oil (PSO) in the treatment of female pattern hair loss (FP …
Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.
Bassiouny EA, El-Samanoudy SI, Abbassi MM, Nada HR, Farid SF. Bassiouny EA, et al. Arch Dermatol Res. 2023 Jul;315(5):1293-1304. doi: 10.1007/s00403-022-02512-2. Epub 2022 Dec 26. Arch Dermatol Res. 2023. PMID: 36571611 Free PMC article. Clinical Trial.
Androgenetic alopecia (AGA) is the most common cause of hair loss in both genders with a higher psychological impact on females. Currently, topical minoxidil is the only FDA-approved treatment for female AGA and it needs life-long application and causes side effects. ...Th …
Androgenetic alopecia (AGA) is the most common cause of hair loss in both genders with a higher psychological impact on females. Currently, …
The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Chen L, Zhang J, Wang L, Wang H, Chen B. Chen L, et al. Aesthetic Plast Surg. 2020 Jun;44(3):962-970. doi: 10.1007/s00266-020-01621-5. Epub 2020 Mar 12. Aesthetic Plast Surg. 2020. PMID: 32166351
BACKGROUND: The combination of finasteride and topical minoxidil has been used for treating patients with androgenetic alopecia (AGA). ...CONCLUSIONS: In patients with AGA, the combination treatment of finasteride and topical minoxidil has better therapeutic efficac …
BACKGROUND: The combination of finasteride and topical minoxidil has been used for treating patients with androgenetic alopecia (AGA) …
Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia.
Pakhomova EE, Smirnova IO. Pakhomova EE, et al. Int J Mol Sci. 2020 Sep 6;21(18):6516. doi: 10.3390/ijms21186516. Int J Mol Sci. 2020. PMID: 32899959 Free PMC article. Clinical Trial.
MATERIALS AND METHODS: The study involved 69 men who were divided into 3 groups who received PRP therapy, minoxidil, and their combination. The clinical efficacy of the therapy was evaluated by the dynamics of morphometric of hairs. To assess cell proliferation antibodies …
MATERIALS AND METHODS: The study involved 69 men who were divided into 3 groups who received PRP therapy, minoxidil, and their combin …
Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.
Hossein Mostafa D, Samadi A, Niknam S, Nasrollahi SA, Guishard A, Firooz A. Hossein Mostafa D, et al. J Pharm Pharm Sci. 2021;24:191-199. doi: 10.18433/jpps31456. J Pharm Pharm Sci. 2021. PMID: 33909554 Free article. Clinical Trial.
METHODS: Forty men, aged 18 to 49 years, were randomly divided into two equal groups to apply either cetirizine 1% or minoxidil 5% solutions. The study was divided into two phases, a 16-week treatment phase either with cetirizine or minoxidil (anagen phase), followe …
METHODS: Forty men, aged 18 to 49 years, were randomly divided into two equal groups to apply either cetirizine 1% or minoxidil 5% so …
188 results